2010
DOI: 10.1038/gt.2010.40
|View full text |Cite
|
Sign up to set email alerts
|

Generation of human TRIM5α mutants with high HIV-1 restriction activity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

12
72
0

Year Published

2011
2011
2020
2020

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 52 publications
(84 citation statements)
references
References 74 publications
12
72
0
Order By: Relevance
“…Numerous mutations within the loop are known to disrupt restriction, and conversely, mutations within the v1 of the human TRIM5α can restore HIV restriction with potency approaching that of the rhesus protein (12,22,23). Moreover, the composition of the v1 loop has been under strong positive selection during recent primate evolution (13).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Numerous mutations within the loop are known to disrupt restriction, and conversely, mutations within the v1 of the human TRIM5α can restore HIV restriction with potency approaching that of the rhesus protein (12,22,23). Moreover, the composition of the v1 loop has been under strong positive selection during recent primate evolution (13).…”
Section: Resultsmentioning
confidence: 99%
“…Just as in the case of antigen-antibody interactions, TRIM5α mutations that affect binding are not necessarily altering direct contacts with the ligand, but rather may act by limiting the conformational space accessible to the v1 variable loop segment. For example, v1 dynamics may help explain how point mutations within the v1 of the human TRIM5α can alter its viral specificity profile or restore its activity against HIV (12,22,23,35,36).…”
Section: Discussionmentioning
confidence: 99%
“…The V1 loop contains many important residues in retroviral capsid interaction, and its flexibility may allow these residues to recognize various viral capsids of different shapes (discussed below). Regardless of the conformation of the V1 loop, some critical residues (residues 332, 335, and 336 of huTRIM5α) that confer restriction specificity (15,16,33,34) are located in the middle of V1. This location could place the residues at the tip of the V1 loop when it is extended ( Fig.…”
Section: Resultsmentioning
confidence: 99%
“…The size of the 32-amino-acid extension (ϳ50 Å) in the v2 loop, comparable to the size of the core structure of B30.2/SPRY (40 to 50 Å), matches the dimensions of an HIV-1 capsid monomer (45 by 35 by 22 Å). The unique breadth of restriction conferred by v2 could be attractive in human gene therapy applications (43). Another remarkable aspect of lemur TRIM5␣ is the pattern of activity against gammaretroviruses.…”
Section: Discussionmentioning
confidence: 99%